This Miami, FL-based company positions itself as a leader in exosome-based biologics, serving licensed providers across aesthetics, regenerative medicine, orthopedics, dentistry, and high-performance wellness rather than treating patients directly in-house.
Its flagship product, Rejuvion Pure™, is a topical exosome formulation built on patented stableSome™ stabilization technology, marketed to accelerate post-procedure healing, reduce inflammation, and minimize downtime after treatments such as microneedling, laser resurfacing, RF, injectables, and surgical procedures. The product is also promoted for supporting skin texture, tone, and elasticity, as well as activating dormant hair follicles and reducing inflammation in thinning areas for hair restoration applications.
Per the site, Rejuvion products are applied topically to the skin's surface and are not intended to be injected or delivered intravenously. The company states its products are not approved as a drug and are not intended to diagnose, treat, cure, or prevent any disease, and that these statements have not been evaluated by the FDA.
We link out to Google's real reviews rather than reproducing review text here.